Saturday, July 4, 2026

How Trump’s Tariff Hike Exposes Lee Jae Myung’s Government’s Trade Agreement Failures

Song Eon-seok criticizes President Lee for neglecting the ratification of the U.S.-Korea tariff agreement, urging urgent National Assembly action.

North Korean Women’s Club Makes First South Korea Visit in Eight Years for Inter-Korean AWCL Semifinal

North Korea's My Hometown Women's Football Club arrives in South Korea for the AFC Women's Champions League semifinals amid tensions.

AI Search on Safari: Apple Confirms It’s Exploring ChatGPT and Perplexity

Apple is considering integrating AI search engines into Safari, but Google remains the default due to a lucrative contract.

Tag: CGBIO

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS

CGBio's DCLASSY PDRN skin booster gains IDE approval for clinical trials targeting eye wrinkles, enhancing patient satisfaction and market competitiveness.

How ExcelOs Inject Revolutionizes Bone Grafting: Insights from the Latest GBR Seminar

CGBIO hosted a hands-on seminar for dental professionals, focusing on practical skills in maxillary sinus lifts and bone grafting techniques.

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

What Makes DOOTH the Game-Changer in Absorbable Sutures? Discover Its Unique Advantages!

CGBio is expanding its aesthetic business by exporting the absorbable suture DOOTH to Japan, aiming for global recognition and regulatory approvals.

K-Spine Surgery: How a Korean Firm Showcased Minimally Invasive Techniques at U.S. Conference

CGBIO successfully held a symposium on minimally invasive spinal surgery, enhancing skills of over 100 global professionals through hands-on training.

IMCAS 2026: Discover How Sijibio Secured Over 70.4 Million USD in Global Contracts

CGBIO showcased its collagen stimulator at IMCAS 2026, securing contracts worth 101.5 billion KRW to strengthen its global market position.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.